Smoking after heart transplantation: An underestimated hazard?

OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 1997-07, Vol.12 (1), p.70-74
Hauptverfasser: NÄGELE, H, KALMAR, P, RÖDIGER, W, STUBBE, H. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 74
container_issue 1
container_start_page 70
container_title European journal of cardio-thoracic surgery
container_volume 12
creator NÄGELE, H
KALMAR, P
RÖDIGER, W
STUBBE, H. M
description OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels < 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P
doi_str_mv 10.1016/S1010-7940(97)00156-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79210960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S1010-7940(97)00156-5</oup_id><sourcerecordid>79210960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</originalsourceid><addsrcrecordid>eNptkF1PHCEUhompUav9CSZzYRp7gR5ggKEXGrutH9WkF2o03hAGGB13d2YLTFL99WXddZMmvQGS87y8Jw9CuwQOCBBxeJ1PwFKVsK_kFwDCBeZraItUkmHJyvsP-f2ObKKPMT4DgGBUbqANRQWFim2ho-tpP267x8I0yYfiyZuQihRMF2cT0yWT2r77Wpx0xdA5H3xM7dQk74on82qCO95B642ZRP9peW-j29MfN6NzfPXr7GJ0coVtqVjCrraClU5S7qxnFfFKEAWigtpwYRh4ZRvrHKWembKuS265I0ZaySXnGWXb6PPi31nofw95DT1to_WTvKPvh6ilogSUgAzyBWhDH2PwjZ6FvHJ40QT03Jt-86bnUrSS-s2b5jm3uywY6ql3q9RSVJ7vLecmWjNpsiHbxhVGJafZbsZggfXD7P_N-J9mPG_Gi0gbk_-zCpkw1kIyyfX5_YMeiW93lxX9qb-zv7DckeM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79210960</pqid></control><display><type>article</type><title>Smoking after heart transplantation: An underestimated hazard?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</creator><creatorcontrib>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</creatorcontrib><description>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels &lt; 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P &lt;0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P &lt; 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/S1010-7940(97)00156-5</identifier><identifier>PMID: 9262083</identifier><identifier>CODEN: EJCSE7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Science B.V</publisher><subject>Biological and medical sciences ; Carboxyhemoglobin - analysis ; Female ; Heart Transplantation - mortality ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Postoperative Period ; Risk Factors ; Smoking ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Survival Analysis</subject><ispartof>European journal of cardio-thoracic surgery, 1997-07, Vol.12 (1), p.70-74</ispartof><rights>1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</citedby><cites>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2752000$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9262083$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NÄGELE, H</creatorcontrib><creatorcontrib>KALMAR, P</creatorcontrib><creatorcontrib>RÖDIGER, W</creatorcontrib><creatorcontrib>STUBBE, H. M</creatorcontrib><title>Smoking after heart transplantation: An underestimated hazard?</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels &lt; 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P &lt;0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P &lt; 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</description><subject>Biological and medical sciences</subject><subject>Carboxyhemoglobin - analysis</subject><subject>Female</subject><subject>Heart Transplantation - mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Postoperative Period</subject><subject>Risk Factors</subject><subject>Smoking</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Survival Analysis</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkF1PHCEUhompUav9CSZzYRp7gR5ggKEXGrutH9WkF2o03hAGGB13d2YLTFL99WXddZMmvQGS87y8Jw9CuwQOCBBxeJ1PwFKVsK_kFwDCBeZraItUkmHJyvsP-f2ObKKPMT4DgGBUbqANRQWFim2ho-tpP267x8I0yYfiyZuQihRMF2cT0yWT2r77Wpx0xdA5H3xM7dQk74on82qCO95B642ZRP9peW-j29MfN6NzfPXr7GJ0coVtqVjCrraClU5S7qxnFfFKEAWigtpwYRh4ZRvrHKWembKuS265I0ZaySXnGWXb6PPi31nofw95DT1to_WTvKPvh6ilogSUgAzyBWhDH2PwjZ6FvHJ40QT03Jt-86bnUrSS-s2b5jm3uywY6ql3q9RSVJ7vLecmWjNpsiHbxhVGJafZbsZggfXD7P_N-J9mPG_Gi0gbk_-zCpkw1kIyyfX5_YMeiW93lxX9qb-zv7DckeM</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>NÄGELE, H</creator><creator>KALMAR, P</creator><creator>RÖDIGER, W</creator><creator>STUBBE, H. M</creator><general>Elsevier Science B.V</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Smoking after heart transplantation: An underestimated hazard?</title><author>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Carboxyhemoglobin - analysis</topic><topic>Female</topic><topic>Heart Transplantation - mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Postoperative Period</topic><topic>Risk Factors</topic><topic>Smoking</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NÄGELE, H</creatorcontrib><creatorcontrib>KALMAR, P</creatorcontrib><creatorcontrib>RÖDIGER, W</creatorcontrib><creatorcontrib>STUBBE, H. M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NÄGELE, H</au><au>KALMAR, P</au><au>RÖDIGER, W</au><au>STUBBE, H. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking after heart transplantation: An underestimated hazard?</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>12</volume><issue>1</issue><spage>70</spage><epage>74</epage><pages>70-74</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><coden>EJCSE7</coden><abstract>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels &lt; 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P &lt;0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P &lt; 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</abstract><cop>Amsterdam</cop><pub>Elsevier Science B.V</pub><pmid>9262083</pmid><doi>10.1016/S1010-7940(97)00156-5</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-7940
ispartof European journal of cardio-thoracic surgery, 1997-07, Vol.12 (1), p.70-74
issn 1010-7940
1873-734X
language eng
recordid cdi_proquest_miscellaneous_79210960
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Biological and medical sciences
Carboxyhemoglobin - analysis
Female
Heart Transplantation - mortality
Humans
Male
Medical sciences
Middle Aged
Multivariate Analysis
Postoperative Period
Risk Factors
Smoking
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Survival Analysis
title Smoking after heart transplantation: An underestimated hazard?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A29%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking%20after%20heart%20transplantation:%20An%20underestimated%20hazard?&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=N%C3%84GELE,%20H&rft.date=1997-07-01&rft.volume=12&rft.issue=1&rft.spage=70&rft.epage=74&rft.pages=70-74&rft.issn=1010-7940&rft.eissn=1873-734X&rft.coden=EJCSE7&rft_id=info:doi/10.1016/S1010-7940(97)00156-5&rft_dat=%3Cproquest_cross%3E79210960%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79210960&rft_id=info:pmid/9262083&rft_oup_id=10.1016/S1010-7940(97)00156-5&rfr_iscdi=true